"As global life expectancy rises, so does demand for solutions that support quality of life in later years — and the gut microbiome is emerging as a key lever.
NBR sat down with Clasado Biosciences' Head of Marketing to unpack the clinical evidence behind Bimuno GOS and what it means for formulators targeting the healthy ageing category.
NBR: What is the core scientific rationale behind the idea that “healthy ageing begins in the gut” and how has evidence evolved in recent years to support this?
SR: From the moment we are born, we carry a relatively high presence of bifidobacteria in the gut. As we age through childhood, that count declines, and with it, the gut microbial composition connected to ageing begins.
What makes this significant is the growing body of research connecting gut microbiome diversity and beneficial bacteria abundance to broader states of ageing, such as inflammation and immunity.
Interestingly, new evidence has emerged that found individuals who reach centenarian status tend to show markedly more diverse gut microbiomes than their younger peers.
Not yet a Subscriber?
This is a small extract of the full article which is available
ONLY to premium content subscribers.
Click below to get premium content on Nutraceutical Business Review.
Subscribe now
Already a subscriber?
Sign in here.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.
